Academician Chen Dong Appointed Chair of BioMap's Immune Expert Committee, Ushering in a New Era of 'Computational Immunology'

Recently, BioMap's Immunology Expert Committee was officially established and held its first plenary meeting.

Professor Dong Chen, academician of the Chinese Academy of Sciences and president of the Shanghai Institute for Innovative Immunotherapy, has been appointed as the chairman of the expert committee. Professor Xu Heji, director of the Department of Rheumatology and Immunology at Shanghai Changzheng Hospital and clinical researcher at the Tsinghua-Peking Center for Life Sciences, has been appointed as the secretary-general of the expert committee. Professor Su Bing, director of the Shanghai Institute of Immunology and professor at Shanghai Jiao Tong University, Professor Zhao Minghui, director of the Peking University Institute of Nephrology and chief physician at Peking University First Hospital, and Professor Hu Xiaoyu, director of the Tsinghua University Institute of Immunology, have been appointed as standing members of the expert committee.

Group Photo of the Experts

As a platform company driven by a bio-computing engine to innovate immunotherapy research and development, BioMap has been committed to the study of cutting-edge immune-related issues since its establishment. It has built an immune computing engine based on single-cell technology, gene-editing technology, high-content machine vision technology, and large-scale machine learning technology. Through extensive immune cohort studies and high-throughput experimental simulations, BioMap has generated a vast amount of unique data, creating the largest immune map in the industry. It possesses a series of capabilities for discovering immune cell targets and designing innovative immunomodulatory drugs. Currently, there are over 50 immune target and drug development projects underway.

Behind these efforts, BioMap has built a professional team of nearly 200 people, including over 40 immunologists, who have collectively published nearly 2,000 papers in the field, with total citations exceeding 120,000. The establishment of the Immunology Expert Committee will bring guidance from several leading figures in the field of immunology, further enhancing BioMap's expertise in immunological disease research and immunotechnology development, and providing direction for the company’s computational immunology platform.

At the first meeting of the Immunology Expert Committee, the experts reviewed the planning of BioMap's Excellence Program in Immunology Atlas (Phase II). Focusing on key topics such as unresolved clinical mechanisms of immune diseases, function-oriented immune cell typing research, immune target combinations, and innovative technologies for immune drug design, they identified a series of R&D projects and industry collaboration initiatives based on computational immunology methods. Additionally, plans were made for the next step in building a large-scale computational immunology innovation R&D platform.

Academician Dong Chen Poses with BioMap Mascot

On serving as the chairman of the Immunology Expert Committee, Academician Dong Chen stated: "BioMap is undertaking a great mission, attempting to decode the complex human immune system and trying to treat and save lives based on this logic. I am very pleased to serve as the chairman of BioMap's Immunology Expert Committee and explore with the company’s team how computation and AI can empower immunological research. We have gathered the brightest minds and the most powerful computing machines and algorithms — an unprecedented endeavor. I believe we will surely succeed in decoding immunity, decoding diseases, and decoding the human body."